Sze H. Tan
11 Hospital Crescent
Singapore, Singapore
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
Journal: JCO global oncology
Published: April 10, 2026
Integrating efficacy and safety profile in advanced HCC: A network meta-analysis of first-line systemic therapies.
Journal: JNCI cancer spectrum
Published: February 09, 2026
Plasma Epstein-Barr virus DNA for disease surveillance in endemic nasopharyngeal carcinoma: Analysis of a real-world database.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 26, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 24, 2025
Impact of COVID-19 pandemic on the implementation of transmission-based precautions.
Journal: The Journal of hospital infection
Published: December 05, 2024
Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes.
Journal: Cell reports. Medicine
Published: September 20, 2024
Trends in Early-Onset Colorectal Cancer in Singapore: Epidemiological Study of a Multiethnic Population.
Journal: JMIR public health and surveillance
Published: June 09, 2024
A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: June 04, 2024
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.
Journal: Asia-Pacific journal of clinical oncology
Published: March 03, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 27, 2023
Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma.
Journal: Oral oncology
Published: November 08, 2023
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure.
Journal: JTO clinical and research reports
Published: May 28, 2023
Last Updated: 09/26/2026